Jump to content

Shares

dune

By dune,
in The Lounge

 Share

Recommended Posts

  • 3 weeks later...
thefunkygibbons

thefunkygibbons

Posted
Posted

Looked at my opening post on this thread

 

One of my holds was Gulf Keystone

 

Now, it is 95% of my portfolio, in part because of its share price

 

My average price is 266p and the price today is 360p

 

Personally I think it will get into double figures this year, although there is some risk. With hindsight I wish I had bought more back in the day, but overall I am sitting on a £13k profit and growing by the day,

 

Do your own research

Link to comment
Share on other sites
Trader

Trader

Posted
Posted (edited)
Looked at my opening post on this thread

 

One of my holds was Gulf Keystone

 

Now, it is 95% of my portfolio, in part because of its share price

 

My average price is 266p and the price today is 360p

 

Personally I think it will get into double figures this year, although there is some risk. With hindsight I wish I had bought more back in the day, but overall I am sitting on a £13k profit and growing by the day,

 

Do your own research

 

See my post on 10th Jan - GKP were 260p then.

 

So all your profit in the last month then - hang on to them.

 

Bet you wish you bought them at 10p though.

 

I repeat Range Resources (RRL currently 11p ish) and Red Emperor Resources (RMP currently 23p ish) are good punts.

 

DYOR

Edited by Trader
Link to comment
Share on other sites
Gemmel

Gemmel

Posted
Posted

Can someone help me. I have stock options in an American software company (Had them before, but never this scenario) and from what I have read I can pay tax upfront on the option price $5 which means I don't have to pay tax on the vesting price. Is that right / legal??

 

Cheers

Link to comment
Share on other sites
thefunkygibbons

thefunkygibbons

Posted
Posted
See my post on 10th Jan - GKP were 260p then.

 

So all your profit in the last month then - hang on to them.

 

Bet you wish you bought them at 10p though.

 

I repeat Range Resources (RRL currently 11p ish) and Red Emperor Resources (RMP currently 23p ish) are good punts.

 

DYOR

 

True

 

My opening purchases were at 149p I think, but I have been adding more (and in bigger tranches, which has pulled the average up

 

I will be holding firm until Takeover now

 

Already up £15k with loads more to come

Link to comment
Share on other sites
  • 2 weeks later...
thefunkygibbons

thefunkygibbons

Posted
Posted

The 11% fall is small compared to recent rises

 

However, it was a MM bear raid designed to liberate shares from the impatient to meet large ii orders

 

GKP is not one for widows and orphans, but the investment case is based around the long term takeover value and that is based on the OIP, not the individual SP movements on a given day

Link to comment
Share on other sites
thefunkygibbons

thefunkygibbons

Posted
Posted
what returns are you expecting?

 

I still expect GKP to go up 3 fold from here

 

The reasons are

- Drill results expected soon from major fields

- Passing of Oil & Gas law in KRG

- Entry onto main LSE FTSE market soon

- Progession into FTSE 100 thereafter

- Bidding war bewteen oil majors, probably Exxon and Sinopac to take over GKP

 

It may take longer than some people hope, but having read around the subject a lot, GKP is probably the route to invest in one of the largest as yet untapped oil discoveries

Link to comment
Share on other sites
dune

dune

Posted
  • Author
Posted

What is interesting is that corporate bonds markets have been picking up again recently, and the gold spot price is rising again AND equity markets are rising.

 

It's not a normal pattern. When corporate bonds/gold does well equities do badly. My belief is that stock markets are completely overvalued and with all the sh/t going on with sovereign debt I can only see the recent rally in the stock markets as a swansong before a long overdue crash

Link to comment
Share on other sites
Draino76

Draino76

Posted
Posted
I'd like to understand more about Technical Analysis - any pointers on where to begin?

 

There is a book called 'Technical Analysis of the Financial Markets' by John Murphy; this is regarded as a bible by most fund managers I know.

 

http://www.bigcharts.com is a great free charting website. Find your stock, then click advanced chart. For upper indicators I use bollinger bands and 2-line moving averages, 50 days. Lower indicators I use MACD, Volume+ and RSI, oh and make the chart big. Look at your stock/bond/commodity over several time periods, eg a year/3 years/ 5 years/ a decade.

 

Also read this; http://stockcharts.com/school/doku.php?id=chart_school

Link to comment
Share on other sites
Draino76

Draino76

Posted
Posted (edited)

Use OHLC. Open High Low Close. You can tell a lot from a stock from its opening and closing price for the day.

 

BTW technical analysis works best for highly liquid stocks. For some of the stocks talked about here such as HMV and RBS, the rules of technical analysis break down in a similar way to physics laws breaking down in a black hole, or accumulators breaking down when betting on Scottish 3rd division matches.

Edited by Draino76
Link to comment
Share on other sites
dune

dune

Posted
  • Author
Posted
Oh noes!

 

It's the long overdue crash of which you speak!

 

What's with the sarcasm?

 

I do think a crash is coming up though not least because Spain is a busted flush and once Greece meets it's destiny then Spain is going down with them.

Link to comment
Share on other sites
dune

dune

Posted
  • Author
Posted

Eurostat has confirmed that the region (the eurozone) shrank by 0.3% in the last three months of 2011.

 

The details of today's GDP data:

 

• Household spending fell by 0.4%

• Exports fell by 0.4%

• Imports fell by 1.2%.

 

This morning's GDP data also confirmed that the eurozone grew by just 0.7% during 2011.

Link to comment
Share on other sites
EBS1980

EBS1980

Posted
Posted
I bought Thomas Cook shares at 15p in January and sold on Thursday for 28p. Quite pleased with that.

 

I asked the point (previous page) about buying Thomas Cook shares when they were only 10p a share, wish i had done it now!

Link to comment
Share on other sites
notnowcato

notnowcato

Posted
Posted
My paper profits on GKP have all disappeared but I knew it would be a wild ride

 

I bought a further £20k worth today, but I bought too soon and these are in loss too

 

Nevermind

 

Nice rally at the end, hope you are in a better, all be it paper, position now.

Link to comment
Share on other sites
dune

dune

Posted
  • Author
Posted

Good news for me, as i'm banking on the banks reigning in lending due to sovereign debt issues. The maths for Spain do not add up and it is inevitable that like Greece they are f/cked. The only possible hope for them both is to devalue (by exiting the euro) to make themselves attractive to investment and it will hapen because there is ultimately no alternative.

 

http://uk.reuters.com/article/2012/03/06/markets-britain-stocks-idUKL5E8E687R20120306

Link to comment
Share on other sites
dune

dune

Posted
  • Author
Posted
Indeed, I found another £17k for a second bit of the cherry at the end of the day

 

I am now sitting on a small paper loss on my portfolio and a much larger paper loss on my SIPP

 

However, it is a long term game

 

I think you're looking at 6 - 10 years before the Markets start looking up in general. I want to get back in, but i'm going to bide my time and am looking at FTSE 4500 before I do.

Link to comment
Share on other sites
  • 1 month later...
  • 2 weeks later...
Seaford Saint

Seaford Saint

Posted
Posted

Look you lot...I want a cheap soft top sports car and a pair £7K hi fi speakers.....and i want to record some more songs.....all expensive hobbies.

 

This is only possible if the share prices stay highish....come on you lot don't be negative. I can't sell my shares until they mature, can you talk the share prices back up just for 4 months :)

Link to comment
Share on other sites
BaffinsPondLife

BaffinsPondLife

Posted
Posted

Big news today

 

 

For immediate release 30 April 2012

 

ANGLE plc

 

("ANGLE" or "the Company")

 

Parsortix Update

 

PARSORTIX GEN2 SEPARATION CASSETTE - DESIGN BREAKTHROUGH

 

ANGLE plc (AIM: AGL), the technology commercialisation company, is delighted to announce that it has successfully achieved crucial new capabilities in the performance of its Parsortix cancer cell separation device.

 

ANGLE has previously demonstrated that its Parsortix separation technology can capture cultured breast cancer, prostate cancer, lung cancer, colon cancer and ovarian cancer cells added to blood (spiked blood) and has successfully captured circulating tumour cells (CTCs) in prostate cancer and breast cancer patient blood.

 

Capture of the very rare CTCs in cancer patient blood may enable the development of a simple blood test to allow the:

 

-- prognostic assessment of patients to predict the likely outcome of their cancer enabling a more informed consideration of their treatment options at the outset;

 

-- monitoring of cancer patients during treatment to assess their progress and determine which treatments are likely to be effective for them;

 

-- post-treatment monitoring of patients in remission for early detection of potential relapse, with the potential to improve treatment success rates for secondary cancers.

 

Primarily as a result of the original design being for the separation of foetal cells from peripheral maternal blood for foetal health diagnostics, the first generation of Parsortix separation technology (known as Parsortix GEN1) was limited to a blood sample volume of circa 1ml and a flow rate of circa 0.1ml/hour. Efficacy and practicality in clinical CTC applications requires separations of 7.5ml blood volumes in times of a few hours.

 

Because of this, ANGLE has previously advised the market of a critical and challenging objective to develop "new separation device designs to allow ease of use in the laboratory addressing critical factors of increasing the volume of blood that can be screened and the speed of blood flow through the device". A related and important issue was that GEN1 captured not only the target cancer cells but also the patient's white blood cells (albeit in a different location within the cassette), which are not cells of interest in the cancer application.

 

Successfully redesigning the cassette to address these key issues has been considered a major technology risk remaining with the Parsortix development and has required a major engineering development effort over the last six months.

 

Highly innovative design and manufacturing by the Parsortix technical team and its partners has generated an advanced new form of the cassette (GEN2). Externally GEN2 maintains the same simple design and size, but internally the patented step arrangement has an entirely new structure and layout.

 

Experimentation using the GEN2 cassettes has demonstrated a tremendous improvement in cassette performance, surpassing our most optimistic expectations.

 

The Parsortix GEN2 cassette has successfully allowed:

 

-- Blood sample volumes of 8ml to be separated. It appears that substantially larger volumes of blood can be processed if required, although this has not yet been demonstrated.

 

-- A flow rate of 8ml/hour to be utilised without any fracture or damage to the target cancer cells. This meets the top end target that we set for the device. However it appears that we may be able to substantially increase flow rates beyond this level, although again this has not yet been demonstrated.

 

-- Near complete reduction in the debris and clogging to which the GEN1 cassette can be prone.

-- Visual identification of cultured cancer cells spiked in healthy whole blood with cancer cell capture and enumeration being accurate to approximately 10% of the cells added for numbers of cancer cells added of 0, 15, 200, and 2,000 cells in volumes of blood ranging from 1ml to 8ml. Bearing in mind that there is a level of statistical variation when adding the spiked cells into the blood, this is indicative of complete capture of the added cancer cells.

 

-- Formal identification of the added cancer cells using industry standard immuno-staining within the cassette for cytokeratin 18, an epithelial marker used to indicate cancer. Again there was very good enumeration of the cells, closely in line with the number of cells spiked in the blood.

 

-- Capture of the target cancer cells without capture of other non-target cells (other than very low levels of red blood cells and white blood cells on the periphery of the cassette) and without any build-up of aggregate or debris, making visualisation and identification of cancer cells even easier.

 

The most challenging separation so far completed was 15 cancer cells added to 8ml of whole blood, which equates to looking for one cancer cell in 2.8 billion other cells. Our complete success (subject to the tolerances of counting the cells) in visually identifying the target cells in this sample within one hour of receiving the sample is testament to the sensitivity of the new Parsortix GEN2 design.

 

We are greatly encouraged by the success of this further development of our technology. Our technical development is proceeding to plan and we are on track to meet the next key milestones, which are:

 

-- Validation of the separation device for other cancer types;

-- Independent third party validation of the performance of the Parsortix CTC separation device by leading cancer research centres including the Paterson Institute for Cancer Research; and

 

-- Development and launch of the Parsortix cancer diagnostic product for research purposes, with initial sales to cancer research centres and pharmaceutical companies developing cancer drugs.

 

Development of the Parsortix cancer diagnostic product for research purposes is in progress and is expected to involve a Parsortix GEN3 cassette as a consumable together with a compact and relatively inexpensive instrument on which to run the separation. This work is in progress and we hope that it will be complete in time for us to take delivery of the first units in Q3 this year. Sales for research purposes can then commence once the product has been tested both in-house and by our partners.

 

ANGLE's Founder and Chief Executive, Andrew Newland, commented:

 

"Solving the critical issues of sample volume and processing time is extremely important. This major breakthrough proves the potential for the Parsortix technology to address the market requirements and in doing so brings us much closer to market launch."

 

For further information:

 

 

ANGLE plc 01483 685830

Andrew Newland, Chief Executive

Ian Griffiths, Finance Director

Cenkos Securities

Stephen Keys, Adrian Hargrave (Nominated

adviser)

Andy Roberts (Sales) 020 7397 8900

Buchanan

Mark Court, Sophie Cowles 020 7466 5000

Scott Harris

Stephen Scott, Harry Dee 0207 653 0030

 

This information is provided by RNS

 

The company news service from the London Stock Exchange

 

END

 

MSCPGUPCCUPPGMB

Link to comment
Share on other sites
  • 2 weeks later...
dune

dune

Posted
  • Author
Posted

It looks to me like there could be some mileage in gold again.

 

http://www.kitco.com/charts/livegold.html

 

Corporate bonds also looking good, with rises in the recent days despite people saying they were overvalued a few weeks back. I've been about 40:60 between bonds and cash since November and won't be changing that much any time soon. I did set a target of ftse 4500 but now I can really see ftse 3000 being possible by the autumn.

 

article-1619305-0D037F4D00000578-610_468x378.jpg

Link to comment
Share on other sites
dune

dune

Posted
  • Author
Posted (edited)
get em quick dune..........the price will rise very quickly before they fall

 

Nah, i'm not touching equities for the time being. It's like catching a falling knife atm. Things are moving along nicely to make some good money in the future. The FTSE is already down about 12% since the new year, and that's nowhere near enough for my liking giving the situation.

Edited by dune
Link to comment
Share on other sites
  • 1 month later...
Burger

Burger

Posted
Posted
Looked at my opening post on this thread

 

One of my holds was Gulf Keystone

 

Now, it is 95% of my portfolio, in part because of its share price

 

My average price is 266p and the price today is 360p

 

Personally I think it will get into double figures this year, although there is some risk. With hindsight I wish I had bought more back in the day, but overall I am sitting on a £13k profit and growing by the day,

 

Do your own research

 

Thought I'd take a quick look at how GKP were doing....160p. Are you still confident about future of this share? Must be a good buy now?

Link to comment
Share on other sites
thefunkygibbons

thefunkygibbons

Posted
Posted

I am still confident about GKP, although the share movements have been really painful

 

I have added shares on the dips and now own 67,918 shares

 

At the moment, I am sitting on a £70k paper loss, which smarts, but not enough to make me make silly decisions

 

At present, I don't have any other money to throw at it, so I will only be slowly adding more from each monthly pay packet

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
 Share
Go to topic listing
×
×
  • Create New...